Experience adjusted life years and critical medical allocations within the British context: which patient should live?

Medicine, Health Care, and Philosophy
Michal Pruski

Abstract

Medical resource allocation is a controversial topic, because in the end it prioritises some peoples' medical problems over those of others. This is less controversial when there is a clear clinical reason for such a prioritisation, but when such a reason is not available people might perceive it as deeming certain individuals more important than others. This article looks at the role of social utility in medical resource allocation, in a situation where the clinical outcome would be identical if either person received the treatment. This situation is explored with a focus on the United Kingdom, but its conclusions have wider applications to any system where healthcare is tax-payer funded. The article proposes an experience adjusted life years system, and discusses its strengths and weaknesses.

References

Sep 16, 1995·BMJ : British Medical Journal·R J Lilford
May 6, 1995·BMJ : British Medical Journal·M M Rivlin
Dec 14, 1996·BMJ : British Medical Journal·A Maynard
Nov 14, 1997·American Journal of Respiratory and Critical Care Medicine
Mar 7, 2001·BMC Medical Ethics·Michael M Rivlin
Jun 1, 2001·Annals of Emergency Medicine·N PesikK V Iserson
Jul 24, 2004·BMJ : British Medical Journal·Michael D Rawlins, Anthony J Culyer
Sep 4, 2007·BMC Health Services Research·Samia A HurstMarion Danis
Feb 3, 2009·Lancet·Govind PersadEzekiel J Emanuel
Sep 10, 2011·Transplant International : Official Journal of the European Society for Organ Transplantation·James Neuberger
Aug 9, 2013·Intensive Care Medicine·Charles L SprungRobert D Truog
Dec 3, 2015·Lancet·Martin HirschUNKNOWN health professionals of Assistance Publique-Hôpitaux de Paris (APHP)

❮ Previous
Next ❯

Citations

Jun 13, 2020·The Medico-legal Journal·Richard Wm Law, Kartina A Choong
Oct 31, 2021·Monash Bioethics Review·Michal Pruski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.